pharmaceutical investing Progenics Pharmaceuticals and ROTOP Pharmaka GmbH Announce European Collaboration
Endocyte and ITM Announce Supply Agreement for No-Carrier-Added Lutetium for the Phase 3 VISION Trial
Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results
Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation
pharmaceutical investing Nymox Reports 5-Year Results From Prospective Randomized Controlled Prostate Cancer Study of Fexapotide Triflutate
Forte Minerals Corp Exhibits at PDAC 2026, Highlighting the Alto Ruri Project's High-Grade Potential Near Barrick's Pierina Mine
NextSource Materials Announces Closing of $25 Million LIFE Offering to Advance UAE Battery Anode Facility
Canadian Securities Exchange Approves Gold Runner Exploration's Option to Acquire the Golden Girl Property from the B-ALL Syndicate in British Columbia's Prolific Golden Triangle
